Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : InterMune (nasdaq)ITMN -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (435)	1/9/2009 9:10:20 PM
From: scaram(o)uche	Respond to of 508

sure!

To: rkrw who wrote (435)	1/9/2009 9:14:05 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 508

So you're saying that holders should sell on any really good news, huh? OK. ;-) pirfenidone..... don't follow the company...... chances are regarded as good? bad? ugly?

To: rkrw who wrote (435)	1/9/2009 10:28:28 PM
From: ghmm	Read Replies (1) \| Respond to of 508

I thought (worried) that too. In general too much is read into what companies do. Sometimes they do things one way and sometimes they don't. I'ld hope if no comments someone questions the time frame exactly. At least is the DB locked. The options trading was quite high for both the January and February. January looked like someone played both sides. February I believe 2k 10's and 5k 20's (going by memory). I wonder what the short position has done the past couple months too! At the current rate, a few more weeks without Pirfenidone news and the stock may go up even on bad results since there won't be any downside left :). This board is quiet for a year and then picks up. If any are interested there is a survey on biotech values board. I think I know how rkrw voted, no secret how i did :). siliconinvestor.com